Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Sartorius AG
  6. Summary
    SRT   DE0007165607

SARTORIUS AG

(SRT)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
11/22/2021 11/23/2021 11/24/2021 11/25/2021 11/26/2021 Date
506(c) 489(c) 493(c) 500(c) 515(c) Last
3 467 6 842 3 897 2 564 7 898 Volume
-2.50% -3.36% +0.82% +1.42% +3.00% Change
More quotes
Estimated financial data (e)
Sales 2021 3 394 M 3 841 M 3 841 M
Net income 2021 411 M 465 M 465 M
Net Debt 2021 1 885 M 2 134 M 2 134 M
P/E ratio 2021 86,6x
Yield 2021 0,26%
Sales 2022 3 820 M 4 323 M 4 323 M
Net income 2022 506 M 573 M 573 M
Net Debt 2022 1 550 M 1 754 M 1 754 M
P/E ratio 2022 66,5x
Yield 2022 0,31%
Capitalization 37 457 M 42 386 M 42 393 M
EV / Sales 2021 11,6x
EV / Sales 2022 10,2x
Nbr of Employees 12 952
Free-Float 35,0%
More Financials
Company
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates through two segments: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers... 
More about the company
Ratings of Sartorius AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about SARTORIUS AG
11/26Sartorius to Invest EUR100 Million in France by 2025, Create Up to 400 Jobs
DJ
11/25Sartorius to Invest Around EUR270 Million in South Korea Expansion
DJ
11/24Sartorius Significantly Expands Activities in South Korea
CI
11/18SARTORIUS : Opens Cell Culture Technology Center
PU
11/12SARTORIUS VORZUEGE : DZ Bank reiterates its Neutral rating
MD
11/11SARTORIUS VORZUEGE : Gets a Sell rating from UBS
MD
11/03Sartorius Honored as “Overall Best Bioprocessing Supplier” Award...
PU
11/01Sartorius Introduces Faster, Higher Capacity Sartolab« RF|BT...
PU
10/28SARTORIUS VORZUEGE : Berenberg remains Neutral
MD
10/27Waters and Sartorius Partner to Help Bioprocess Scientists...
PU
10/25SARTORIUS VORZUEGE : NorldLB reiterates its Neutral rating
MD
10/21SARTORIUS VORZUEGE : Warburg Research remains its Buy rating
MD
10/21SARTORIUS VORZUEGE : Receives a Buy rating from JP Morgan
MD
10/20SARTORIUS : Conference Call 9M|2021 Presentation
PU
10/20SARTORIUS VORZUEGE : Kepler Cheuvreux reiterates its Buy rating
MD
More news
News in other languages on SARTORIUS AG
11/26Sartorius investiert 100 Mio Euro in Frankreich bis 2025
11/26MÄRKTE EUROPA/Covid-Ängste sorgen für massiven Abverkauf
11/26XETRA-SCHLUSS/Ausverkauf - B.1.1.529 beendet Weihnachtsrally
11/26MÄRKTE EUROPA/Ausverkauf hält an - Schwarzer Freitag für Touristiksektor
11/26MÄRKTE EUROPA/Börsen unter Druck, aber mit Stabilisierungsansätzen
More news
Analyst Recommendations on SARTORIUS AG
More recommendations
Stock Trading Strategies
SARTORIUS AG - 07/28
No turn-around in sight
BUY
More Stock Trading Analysis
Chart SARTORIUS AG
Duration : Period :
Sartorius AG Technical Analysis Chart | SRT | DE0007165607 | MarketScreener
Technical analysis trends SARTORIUS AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Last Close Price 515,00 €
Average target price 483,55 €
Spread / Average Target -6,11%
EPS Revisions
Managers and Directors
Joachim Kreuzburg Chief Executive Officer
Rainer Lehmann Chief Financial Officer
Lothar Kappich Chairman-Supervisory Board
Oscar-Werner Reif Head-Research & Development
Volker Niebel Head-Production, Procurement & Business Operations
Sector and Competitors
1st jan.Capi. (M$)
SARTORIUS AG49.28%42 386
BIOTAGE AB (PUBL)89.21%1 906
REVENIO GROUP OYJ9.24%1 652
VAREX IMAGING CORPORATION76.68%1 162
CELLAVISION AB (PUBL)15.90%932
908 DEVICES INC.-59.00%651